Lykos Therapeutics Shakeup Continues With Leadership Change

September 6, 2024

Analysis: MDMA Setback Shows Psychedelic Medicine Still Has Work Ahead

June 7, 2024

Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment

May 9, 2024